Neurocrine Biosciences (NBIX) Shares Outstanding (Diluted) (2010 - 2026)
Neurocrine Biosciences (NBIX) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 833.33 Mn |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 173.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 104.20 Mn |
| Mar 31, 2026 | 103.40 Mn |
| Dec 31, 2025 | 102.50 Mn |
| Sep 30, 2025 | 102.50 Mn |
| Jun 30, 2025 | 101.00 Mn |
| Mar 31, 2025 | 102.50 Mn |
| Dec 31, 2024 | 103.70 Mn |
| Sep 30, 2024 | 104.30 Mn |
| Jun 30, 2024 | 103.90 Mn |
| Mar 31, 2024 | 103.60 Mn |
| Dec 31, 2023 | 101.00 Mn |
| Sep 30, 2023 | 101.10 Mn |
| Jun 30, 2023 | 100.20 Mn |
| Mar 31, 2023 | 97.10 Mn |
| Dec 31, 2022 | 98.90 Mn |
| Sep 30, 2022 | 99.00 Mn |
| Jun 30, 2022 | 95.60 Mn |
| Mar 31, 2022 | 97.60 Mn |
| Dec 31, 2021 | 97.90 Mn |
| Sep 30, 2021 | 97.70 Mn |